BELFIORI, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 151
AS - Asia 132
EU - Europa 132
SA - Sud America 2
AF - Africa 1
Totale 418
Nazione #
US - Stati Uniti d'America 151
CN - Cina 74
IT - Italia 61
SG - Singapore 52
RU - Federazione Russa 26
SE - Svezia 15
FI - Finlandia 12
IN - India 6
DE - Germania 5
IE - Irlanda 4
NL - Olanda 4
FR - Francia 3
AT - Austria 2
BR - Brasile 2
TG - Togo 1
Totale 418
Città #
Singapore 40
Ashburn 31
Shanghai 29
Boardman 24
Milan 23
New York 20
Dallas 9
Helsinki 8
Pune 6
Carlsbad 5
Jiaxing 5
Verdellino 5
Dublin 4
Guangzhou 4
Lappeenranta 4
Moscow 4
Pisa 4
Seattle 4
Amsterdam 3
Rome 3
Bolzano 2
Buffalo 2
Campodolcino 2
Commessaggio 2
Cordenons 2
Cosenza 2
Jinan 2
Atlanta 1
Cernusco sul Naviglio 1
Chongqing 1
Dalian 1
Ferrara 1
Florence 1
Fort Worth 1
Frankfurt am Main 1
Fuzhou 1
Hachenburg 1
Hangzhou 1
Laojunmiao 1
Lomé 1
Los Angeles 1
Lu'an 1
Macerata 1
Orzinuovi 1
Phoenix 1
Quanzhou 1
San Martino Buon Albergo 1
Shantou 1
Shenyang 1
Shenzhen 1
Vienna 1
Washington 1
Wuhu 1
Xi'an 1
Totale 276
Nome #
Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system 27
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 24
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 23
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 23
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 20
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 20
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 19
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 18
Risk factors for the occurrence of ampullary tumors: A case-control study 17
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 17
Improving diagnostic accuracy and appropriate indications for surgery in pancreatic cystic neoplasms: the role of EUS 16
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 15
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 15
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making 14
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 14
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer 14
Indications to total pancreatectomy for positive neck margin after partial pancreatectomy: a review of a slippery ground 14
ASO Visual Abstract: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biologic R2 Definition" 14
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology 13
Surgical Planning for “Borderline Resectable” and “Locally Advanced” Pancreatic Cancer During Open Pancreatic Resection 13
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 12
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 12
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 11
ASO Author Reflections: Long-Term Survivors after Upfront Resection for Pancreatic Cancer: Do They Really Exist? 11
Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort 11
Implications of pregnancy on MCN of the pancreas: A multicentric case-control study 10
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 10
Correction to: Intraperitoneal prophylactic drain after pancreaticoduodenectomy: an Italian survey (Updates in Surgery, (2024), 76, 3, (923-932), 10.1007/s13304-024-01836-0) 10
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 9
Real-world costs and dynamics of surveillance in patients who underwent surgery for low-risk branch duct intraductal papillary mucinous neoplasms 9
Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study 9
Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancer 8
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy 7
Endoscopic and Surgical Management of Non-Metastatic Ampullary Neuroendocrine Neoplasia: A Multi-Institutional Pancreas2000/EPC Study 7
ASO Author Reflections: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: The Challenge of Minimal Residual Disease 6
Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation 6
ASO Visual Abstract: Surgery for IPMN of the Pancreas-Preoperative Factors Tipping the Scale of Decision-Making 4
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 1
Totale 503
Categoria #
all - tutte 5.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202345 0 0 0 0 2 6 10 10 0 0 10 7
2023/2024237 3 12 27 31 23 39 11 22 3 0 31 35
2024/2025221 60 20 40 66 35 0 0 0 0 0 0 0
Totale 503